Screener
Tandem Diabetes Care TNDM Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001438133-26-000125
| Assets | June 30, 2026 / (Unaudited) | December 31, 2025 / (Note 1) |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $62,818 | $90,634 |
| Short-term investments | 393,178 | 202,032 |
| Accounts receivable, net | 162,065 | 165,491 |
| Inventories | 135,106 | 128,769 |
| Prepaid and other current assets | 51,472 | 31,217 |
| Total current assets | 804,639 | 618,143 |
| Property and equipment, net | 84,501 | 83,580 |
Item 1. Financial Statements.
FAQ
- What is Tandem Diabetes Care's short-term investments?
- Tandem Diabetes Care (TNDM) reported short-term investments of $393.18M in Q2 2026.
- How has Tandem Diabetes Care's short-term investments changed year-over-year?
- Tandem Diabetes Care's short-term investments increased by 56.5% year-over-year, from $251.25M to $393.18M.
- What is the long-term trend for Tandem Diabetes Care's short-term investments?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's short-term investments has grown at a -12.3% compound annual growth rate (CAGR), from $390.32M to $202.03M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Tandem Diabetes Care's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude